|
VDP-112 [Assessment] Cyclarity - Novel cyclodextrin molecules for multiple aging-related diseases
|
|
3
|
942
|
August 7, 2023
|
|
VDP-113 [Governance] - Incentive Structure Framework for IP-NFT Deals and Equity Assessments in VitaDAO
|
|
6
|
519
|
August 7, 2023
|
|
VDP-114 VitaDAO's Conference Sponsorship Proposal
|
|
3
|
390
|
August 9, 2023
|
|
VDP-98 [Funding]: ETTA Biotechnology
|
|
7
|
888
|
July 27, 2023
|
|
VDP-90 [Assessment] MutagenTech- Somatic mutation sequencing technology
|
|
6
|
906
|
July 25, 2023
|
|
VDP-103 [Funding]: Mutation-Specific Codon Suppression for Aging and Longevity
|
|
36
|
2338
|
July 19, 2023
|
|
VDP-105 [Outreach]: Promoting Longevity Discourse in the USA Presidential Election
|
|
9
|
570
|
July 18, 2023
|
|
VDP-109 [Funding]: Web3ification of TLDR longevity research peer review service
|
|
15
|
926
|
July 20, 2023
|
|
VDP-111: VITA-FAST Governance and Constitution
|
|
20
|
1136
|
July 13, 2023
|
|
VDP-106 [Governance] Proposal eligibility criteria to enter the VitaDAO deal-flow funnel
|
|
29
|
2700
|
July 6, 2023
|
|
VDP-110: Allocating Resources for the Next Batch of VitaDAO Longevity Fellows
|
|
0
|
589
|
July 5, 2023
|
|
VDP-104 [Governance]: Amendment to VDP-100 (Fractionalization of Newcastle-Korolchuk)
|
|
7
|
537
|
June 30, 2023
|
|
VDP 107 [Governance] - Dealflow Steward Restructuring & Network Steward Preparation
|
|
9
|
1121
|
June 30, 2023
|
|
VDP-93 [Governance]: Proposal to Revise Governance Workflow
|
|
22
|
1306
|
July 19, 2023
|
|
VDP-102 [Governance]: Portfolio Management Process
|
|
14
|
1199
|
July 19, 2023
|
|
VDP-99: Bridging VITA to Optimism, Arbitrum and Polygon
|
|
7
|
889
|
May 29, 2023
|
|
VDP-100 (Fractionalization of Newcastle-Korolchuk IP-NFT)
|
|
22
|
2156
|
May 24, 2023
|
|
VDP-101 Proposal to Establish an Operating Entity for VitaDAO
|
|
12
|
1289
|
June 9, 2023
|
|
VDP-91: TelomEYE
|
|
5
|
748
|
May 24, 2023
|
|
VDP-94 Proposal to Reallocate VITA Tokens
|
|
4
|
1119
|
April 26, 2023
|
|
VDP-97 [Governance]: $VITA allocations for community & awareness contributors
|
|
3
|
905
|
May 2, 2023
|
|
VDP-80 [Assessment]: ImmuneAGE
|
|
14
|
1623
|
April 5, 2023
|
|
VDP-72 Proposal to Approve the Compensation Policy for 2023
|
|
22
|
2395
|
March 27, 2023
|
|
VDP-63 Anticancer and pro-longevity effects of high molecular weight hyaluronic acid (from naked mole rat to human) - Vera Gorbunova
|
|
18
|
2387
|
March 24, 2023
|
|
VDP-87 [Assessment] Zoe Biosciences
|
|
1
|
1070
|
March 24, 2023
|
|
VDP-81 [Funding]: Amplio Pharma
|
|
11
|
1401
|
March 21, 2023
|
|
VDP-85 [Assessment] HDAX Therapeutics
|
|
12
|
1427
|
March 20, 2023
|
|
2023 VitaDAO Travel Authorization and Policy
|
|
7
|
707
|
March 29, 2023
|
|
VDP-73 [Governance]: Fractionalization of ApoptoSENS IP-NFT
|
|
39
|
2000
|
March 27, 2023
|
|
VDP-74 [Assessment]: Etheros Pharma - Jack Scannell
|
|
10
|
1701
|
March 16, 2023
|